| Title | [Pneumocystis jiroveci pneumonia during infliximab therapy] |
| Author(s) | Josephson ME, Kristensen LH, Andersen VC |
| Institution | Regionshospitalet Viborg, Medicinsk Afdeling, Viborg. |
| Source | Ugeskr Laeger 2008 Jun 9; 170(24):2159-60. |
| Abstract | The treatment of ulcerative colitis has improved since the appearance of Tumor Necrosis Factor (TNF)-alpha inhibitors. However, the use of TNF-alpha inhibitors increases the risk of opportunistic infections. We describe two cases of Pneumocystis jiroveci pneumonia during infliximab therapy for active ulcerative colitis. They were successfully treated with sulfametoxazole/trimetroprim. High awareness of P. jiroveci pneumonia in patients who develop pulmonary symptoms with hypoxia during TNF-alpha modulator therapy is recommended. |
| Language | dan |
| Pub Type(s) | English Abstract
Journal Article
|
| PubMed ID | 18565304 |
